Progress in the development of selective nitric oxide synthase (NOS) inhibitors.
about
Structure-Based Design and Synthesis of N ω -Nitro- l -Arginine-Containing Peptidomimetics as Selective Inhibitors of Neuronal Nitric Oxide Synthase. Displacement of the Heme Structural WaterMinimal Pharmacophoric Elements and Fragment Hopping, an Approach Directed at Molecular Diversity and Isozyme Selectivity. Design of Selective Neuronal Nitric Oxide Synthase InhibitorsUnexpected Binding Modes of Nitric Oxide Synthase Inhibitors Effective in the Prevention of a Cerebral Palsy Phenotype in an Animal ModelExploration of the Active Site of Neuronal Nitric Oxide Synthase by the Design and Synthesis of Pyrrolidinomethyl 2-Aminopyridine DerivativesInducible heat shock protein 70 kD and inducible nitric oxide synthase in hemorrhage/resuscitation-induced injuryCyanidin-3-glucoside suppresses cytokine-induced inflammatory response in human intestinal cells: comparison with 5-aminosalicylic acidCombination of chiral linkers with thiophenecarboximidamide heads to improve the selectivity of inhibitors of neuronal nitric oxide synthase.Substance P and the neurokinin-1 receptor regulate electroencephalogram non-rapid eye movement sleep slow-wave activity locallySymmetric double-headed aminopyridines, a novel strategy for potent and membrane-permeable inhibitors of neuronal nitric oxide synthaseInhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on I-kappaBalpha phosphorylation, C/EBP and AP-1 activation.Cerebrovascular risk factors in Alzheimer's disease: brain hemodynamics and pharmacogenomic implications.Luteolin is a bioflavonoid that attenuates adipocyte-derived inflammatory responses via suppression of nuclear factor-κB/mitogen-activated protein kinases pathway.Nitric oxide: considerations for the treatment of ischemic stroke.How to control NO production in cells: N(omega),N(omega)-dimethyl-L-arginine dimethylaminohydrolase as a novel drug target.Neurobiological mechanisms of pain in sickle cell disease.Conformationally restricted dipeptide amides as potent and selective neuronal nitric oxide synthase inhibitorsThe role of nitric oxide in osteoarthritis.Neuronal nitric oxide synthase is necessary for elimination of Giardia lamblia infections in mice.Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping.A cellular model for screening neuronal nitric oxide synthase inhibitorsHyperperfusion in progressive multifocal leukoencephalopathy is associated with disease progression and absence of immune reconstitution inflammatory syndromeConcise route to the chiral pyrrolidine core of selective inhibitors of neuronal nitric oxide.Novel nitric oxide synthase inhibitors: a patent review.Developing anti-inflammatory therapeutics for patients with osteoarthritis.Re(I) and Tc(I) complexes for targeting nitric oxide synthase: influence of the chelator in the affinity for the enzyme.(5R)-5-hydroxytriptolide (LLDT-8) prevents collagen-induced arthritis through OPG/RANK/RANKL signaling in a rat model of rheumatoid arthritisAnti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-κB activation in Caco-2 and SW480 human colon cancer cells.Eudesmanolides from Taraxacum mongolicum and their inhibitory effects on the production of nitric oxide.Inhibitory effect of Agrimoniae Herba on lipopolysaccharide-induced nitric oxide and proinflammatory cytokine production in BV2 microglial cells.A homogeneous fluorescent cell-based assay for detection of heterologously expressed nitric oxide synthase activity.Repeated Mandibular Extension in Rat: A Procedure to Modulate the Cerebral Arteriolar ToneDesign and Synthesis of Imidazopyrimidine Derivatives as Potent iNOS Dimerization Inhibitors.Role of Gasotransmitters in Oxidative Stresses, Neuroinflammation, and Neuronal Repair.Suppression of nitric oxide synthase by thienodolin in lipopolysaccharide-stimulated RAW 264.7 murine macrophage cells.Role of the endothelium and nitric oxide synthases in modulating superoxide formation induced by endotoxin and cytokines in porcine pulmonary arteries.Pharmacokinetics, metabolism and excretion of an inhibitor of inducible nitric oxide synthase, L-NIL-TA, in dog.Involvement of neuronal, inducible and endothelial nitric oxide synthases in capsaicin-induced muscle hypersensitivity.Anti-inflammatory Effects of Galactose-Taurine Sodium Salt: A Taurine Derivate in Zebrafish In Vivo Model.The role of nitric oxide in stroke.Structure elucidation of a new triterpene from Rhus trichocarpa roots.
P2860
Q27644394-9D1121B1-F0BD-4632-BC0E-F9152CFE4D43Q27649995-A639FF71-16D4-4269-B8E8-B5D9F177E112Q27660323-2A832E98-6295-47D5-BAFD-5A349DFE6215Q27665170-0BA6DDC8-34D6-4D98-B6F0-F05AEF4CE606Q28300549-5E6E2FF3-F18F-4FAE-9896-B864CCE63BB6Q28536900-FC71F3C6-2AE1-4D2A-95A3-1473048C189BQ34379221-55A8F85A-F0D7-4E08-9290-07478FB70369Q34718001-9FE7CD27-CC77-4972-87B5-F65514A53BF5Q34770661-B14A63CE-0D3A-4EE0-A290-77E4726E3BA5Q35045262-66DD20AC-66E7-4E19-9800-E7AB645BBCA2Q35540359-AEBA25DE-3138-4D5E-9636-B11ACE178149Q35910369-877EF0CF-D5BB-4BB7-91DD-381AF00D2AADQ36079329-66E23007-D4A8-4E1A-84CB-ACB0FA42E347Q36471209-520A084C-D2A8-4F10-8458-A2287F85E701Q36831700-A7D8FFA8-6B3C-4B54-997A-D09BD00F5C2AQ36840543-3B79AFE4-B283-4881-AD73-5579CD20FA50Q36939711-7CEEE566-D8C7-4976-9FA1-7563217093B6Q36978996-F508E2E2-5B36-4D65-8C60-47F9264AE542Q37147032-EE65598E-7579-4543-8E39-24A25020E694Q37207509-A952660A-5920-49B2-ABAA-4B124CEA95F3Q37256223-2EE83929-FBC6-4180-A419-3365FE160063Q37439981-EB3BFFD7-6C89-4794-836D-295FD919302AQ37845397-00CE7E21-E750-406D-BC3B-A608A673816CQ38833741-A002BF02-5E4D-4118-A75F-61FCD67A42BBQ38884546-8DDB696B-5DA2-4E72-A02C-2B35F03B67BEQ39157409-8E643ACD-AA33-4EA7-BC3A-6C4DEA2C1645Q39411151-7E17B8FE-E114-4FB8-8904-A0C836D5CAD9Q39563596-0D8305E3-D48B-4431-9455-88891370BF03Q39743902-894B7F61-4323-42C8-B5F4-9F6973680C61Q40360473-46C485E3-5F0D-4C3A-A399-700D4F365FD1Q41605980-9A96F91E-7F1D-4E00-A67C-29CBD457612AQ41810165-2B85BB75-705C-4298-82A4-6B13929D4440Q42136680-D4DCB072-EF3B-4D48-B737-8A3D819C3CBBQ42149639-6899FBF5-082A-4048-ADE3-354CEEE84949Q43059405-41920803-C814-48C0-879F-49036FB9489FQ44683313-28060634-5BA3-4F28-A0DE-60BF635901A3Q46197283-8FB56648-DDB1-4129-B75F-F4E83F768A95Q46315142-E4CF8067-F0FC-416D-8FE1-7D2C244BC011Q47164628-7EB41655-449B-4F52-9D17-35E9C4614AC0Q48103543-D672059C-93B3-4647-9D01-64B910EF2E7B
P2860
Progress in the development of selective nitric oxide synthase (NOS) inhibitors.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Progress in the development of selective nitric oxide synthase (NOS) inhibitors.
@ast
Progress in the development of selective nitric oxide synthase (NOS) inhibitors.
@en
Progress in the development of selective nitric oxide synthase
@nl
type
label
Progress in the development of selective nitric oxide synthase (NOS) inhibitors.
@ast
Progress in the development of selective nitric oxide synthase (NOS) inhibitors.
@en
Progress in the development of selective nitric oxide synthase
@nl
prefLabel
Progress in the development of selective nitric oxide synthase (NOS) inhibitors.
@ast
Progress in the development of selective nitric oxide synthase (NOS) inhibitors.
@en
Progress in the development of selective nitric oxide synthase
@nl
P2093
P356
P1476
Progress in the development of selective nitric oxide synthase (NOS) inhibitors
@en
P2093
P304
P356
10.2174/1381612023396375
P577
2002-01-01T00:00:00Z